ALAnding Liu

Anding Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anding Liu has a total of 109 co-authors. Here are the top co-authors by number of shared publications:

  • Cuntai Zhang

    Department of Geriatrics, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

    4 shared publications
  • Guangyu Liang

    Key Laboratory of Vascular Aging, Ministry of Education, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

    4 shared publications
  • Jiankun Yang

    Experimental Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    4 shared publications
  • Xiao Yang

    Experimental Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    4 shared publications
  • Yan Lin

    Experimental Medicine Center, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

    4 shared publications
  • Haoshu Fang

    Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China

    3 shared publications

Latest Publications

  • Open Access

    Single‐Cell Mapping Identifies Aging‐Associated Neutrophil Remodeling Across Multiple Organs

    by Yuman Wang, Teding Chang, Yangguang Fu, Guangyu Liang, Huicheng Liu, Le Zhang, Jinhua Yan, Man Liu, Anding Liu, Cuntai Zhang

    Aging is accompanied by progressive immune remodeling and functional decline across multiple organs. However, the role of neutrophils and their heterogeneous states in these processes remains incompletely understood. Here we integrated single‐cell RNA sequencing datasets from multiple organs of young and aged mice to characterize aging‐associated neutrophil remodeling. We identified organ‐dependent changes in neutrophil abundance and state composition, together with neutrophil subsets enriched for inflammatory, oxidative stress, complement, and IL‐6‐related transcriptional programs. In vitro, exposure to conditioned media from neutrophils isolated from aged mice or IL‐6‐stimulated neutrophil‐like cells increased inflammatory and senescence‐associated responses in vascular smooth muscle and hepatocyte‐derived cells. Bone marrow single‐cell analysis further revealed aging‐associated shifts in progenitor composition and transcriptional states, including an old‐enriched HPC11 population characterized by enhanced myeloid priming. Silico perturbation analysis nominated FGF didate regulators of HPC subtype‐specific transcriptional programs. Together, our study provides a multi‐organ single‐cell resource for defining neutrophil remodeling during aging and highlights candidate neutrophil states and potential signaling axes associated with age‐related inflammatory tissue environments.

  • Top Cited Papers

    Mechanisms of endothelial senescence and vascular aging

    by Qiao Li, Zonghao Qian, Yuzhen Huang, Xiao Yang, Jiankun Yang, Nanyin Xiao, Guangyu Liang, Heng Zhang, Yanguang Fu, Yan Lin, et al.

    Scope Cardiovascular disease (CVD) is a major cause of mortality, especially in the aging population. Aging is one of the main risk factors contributing to CVD, leading to early mortality and a decline in the quality of life. Vascular aging is closely linked with atherosclerosis, diabetes, hypertension, stroke, heart failure, and peripheral arterial diseases. Elucidating the cellular and molecular mechanisms underlying vascular aging help to develop therapeutic strategies that can address age-related vascular diseases and decrease the rate of morbidity and mortality among the older population. Endothelial cells located on the interior layer of blood vessels. Intima layers of vascular vessels are damaged and remodeled during vascular aging. The dysfunction of smooth muscle cells and endothelial cells plays key roles in vascular aging. Common pathological changes during vascular aging include arterial stiffness, calcification, and atherosclerosis. Endothelial cell senescence is driven by complex underlying mechanisms. The complex regulation of aging and antiaging network in endothelial cells involve several factors, such as Klotho protein, nitric oxide, fibroblast growth factor 21 (FGF21), and SIRT family members. Objectives This review aims to systematically delineate the mechanisms underlying the endothelial senescence. Methodology The publications on the endothelial cell senescence mechanisms and its roles in vascular aging and aging related diseases are comprehensively investigated and summarized. In this review, the roles of various components in endothelial cell senescence are discussed to elucidate the underlying molecular mechanisms of endothelial cell senescence and identify potential therapeutic targets.


  • Systemic aging and aging‐related diseases

    by Qiao Li, Nanyin Xiao, Heng Zhang, Guangyu Liang, Yan Lin, Zonghao Qian, Xiao Yang, Jiankun Yang, Yanguang Fu, Cuntai Zhang, et al.

    Aging is a biological process along with systemic and multiple organ dysfunction. It is more and more recognized that aging is a systemic disease instead of a single‐organ functional disorder. Systemic aging plays a profound role in multiple diseases including neurodegenerative diseases, cardiovascular diseases, and malignant diseases. Aged organs communicate with other organs and accelerate aging. Skeletal muscle, heart, bone marrow, skin, and liver communicate with each other through organ–organ crosstalk. The crosstalk can be mediated by metabolites including lipids, glucose, short‐chain fatty acids (SCFA), inflammatory cytokines, and exosomes. Metabolic disorders including hyperglycemia, hyperinsulinemia, and hypercholesterolemia caused by chronic diseases accelerate hallmarks of aging. Systemic aging leads to the destruction of systemic hemostasis, causes the release of inflammatory cytokines, senescence‐associated secretory phenotype (SASP), and the imbalance of microbiota composition. Released inflammatory factors further aggregate senescence, which promotes the aging of multiple solid organs. Targeting senescence or delaying aging is emerging as a critical health strategy for solving age‐related diseases, especially in the old population. In the current review, we will delineate the mechanisms of organ crosstalk in systemic aging and age‐related diseases to provide therapeutic targets for delaying aging.


  • Regulatory Roles of Exosomes in Aging and Aging-Related Diseases

    by Nanyin Xiao, Qiao Li, Guangyu Liang, Zonghao Qian, Yan Lin, Heng Zhang, Yangguang Fu, Xiao Yang, Cun-Tai Zhang, Jiankun Yang, et al.

    Exosomes are small vesicles with diameters ranging from 30 to 150 nm. They originate from cellular endocytic systems. These vesicles contain a rich payload of biomolecules, including proteins, nucleic acids, lipids, and metabolic products. Exosomes mediate intercellular communication and are key regulators of a diverse array of biological processes, such as oxidative stress and chronic inflammation. Furthermore, exosomes have been implicated in the pathogenesis of infectious diseases, autoimmune disorders, and cancer. Aging is closely associated with the onset and progression of numerous diseases and is significantly influenced by exosomes. Recent studies have consistently highlighted the important functions of exosomes in the regulation of cellular senescence. Additionally, research has explored their potential to delay aging, such as the alleviatory effects of stem cell-derived exosomes on the aging process, which offers broad potential for the development and application of exosomes as anti-aging therapeutic strategies. This review aims to comprehensively investigate the multifaceted impact of exosomes while concurrently evaluating their potential applications and underscoring their strategic significance in advancing anti-aging strategies.


  • Open Access

    Lipopolysaccharide binding protein resists hepatic oxidative stress by regulating lipid droplet homeostasis

    by Qilun Zhang, Xuting Shen, Xin Yuan, Jing Huang, Yaling Zhu, Tengteng Zhu, Tao Zhang, Haibo Wu, Qian Wu, Yinguang Fan, et al.

    Oxidative stress-induced lipid accumulation is mediated by lipid droplets (LDs) homeostasis, which sequester vulnerable unsaturated triglycerides into LDs to prevent further peroxidation. Here we identify the upregulation of lipopolysaccharide-binding protein (LBP) and its trafficking through LDs as a mechanism for modulating LD homeostasis in response to oxidative stress. Our results suggest that LBP induces lipid accumulation by controlling lipid-redox homeostasis through its lipid-capture activity, sorting unsaturated triglycerides into LDs. N-acetyl-L-cysteine treatment reduces LBP-mediated triglycerides accumulation by phospholipid/triglycerides competition and Peroxiredoxin 4, a redox state sensor of LBP that regulates the shuttle of LBP from LDs. Furthermore, chronic stress upregulates LBP expression, leading to insulin resistance and obesity. Our findings contribute to the understanding of the role of LBP in regulating LD homeostasis and against cellular peroxidative injury. These insights could inform the development of redox-based therapies for alleviating oxidative stress-induced metabolic dysfunction.


  • Early application of IFNγ mediated the persistence of HBV in an HBV mouse model

    by Jingjiao Song, Xiliang Sun, Yun Zhou, Sheng Li, Jun Wu, Lu Yang, Di Zhou, Yan Yang, Anding Liu, Mengji Lu, et al.


  • Calcitriol ameliorates the progression of hepatic fibrosis through autophagy-related gene 16-like 1-mediated autophagy

    by Enshuang Guo, Huixing Yuan, Renlong Li, Jiankun Yang, Shenpei Liu, Anding Liu, Xiaojing Jiang


  • Single‐cell transcriptome analysis of aging mouse liver

    by Yan Lin, Ying Li, Guangyu Liang, Xiao Yang, Jiankun Yang, Qi Hu, Jian Sun, Cuntai Zhang, Haoshu Fang, Anding Liu

    Aging has a great impact on the liver, which causes a loss of physiological integrity and an increase in susceptibility to injury, but many of the underlying molecular and cellular processes remain unclear. Here, we performed a comprehensive single‐cell transcriptional profiling of the liver during aging. Our data showed that aging affected the cellular composition of the liver. The increase in inflammatory cells including neutrophils and monocyte‐derived macrophages, as well as in inflammatory cytokines, could indicate an inflammatory tissue microenvironment in aged livers. Moreover, aging drove a distinct transcriptional course in each cell type. The commonly significant up‐regulated genes were S100a8 , S100a9, and RNA‐binding motif protein 3 across all cell types. Aging‐related pathways such as biosynthesis, metabolism, and oxidative stress were up‐regulated in aged livers. Additionally, key ligand–receptor pairs for intercellular communication, primarily linked to macrophage migration inhibitory factor, transforming growth factor‐β, and complement signaling, were also elevated. Furthermore, hepatic stellate cells (HSCs) serve as the prominent hub for intrahepatic signaling. HSCs acquired an “activated” phenotype, which may be involved in the increased intrahepatic vascular tone and fibrosis with aging. Liver sinusoidal endothelial cells derived from aged livers were pseudocapillarized and procontractile, and exhibited down‐regulation of genes involved in vascular development and homeostasis. Moreover, the aging‐related changes in cellular composition and gene expression were reversed by caloric restriction. Collectively, the present study suggests liver aging is linked to a significant liver sinusoidal deregulation and a moderate pro‐inflammatory state, providing a potential concept for understanding the mechanism of liver aging.


  • Open Access

    Overview of Innate Immune Cell Landscape in Liver Aging

    by Yan Lin, Qiao Li, Guangyu Liang, Nanyin Xiao, Jiankun Yang, Xiao Yang, Heng Zhang, Cuntai Zhang, Anding Liu

    Aging is a biological process with a gradual decline in functional capacity, and this process often enhances the risk of chronic disease morbidity and mortality. With advanced age, the immune system undergoes a process of remodeling that can lead to a chronic inflammatory state, termed immunosenescence and inflammaging, respectively. Immunosenescence is accompanied by changes in the number, proportion, and functional capacity of the innate immune cells. The accumulation of dysfunctional immune cells and the presence of low-grade inflammation can lead to organ damage and expedite the aging process. The liver, crucial in regulating the body’s metabolism and immune function, is not exempt from these effects. Age-related modifications affect its immune function and regenerative abilities, potentially increasing the prevalence of age-related liver diseases. While aging’s impact on the liver is relatively less severe compared to other organ systems, it still experiences an infiltration of innate immune cells and heightened inflammation levels. This review will elaborate on how aging affects the liver’s innate immune cells, such as neutrophils, macrophages, dendritic cells, mast cells, and innate lymphoid cells. It will also explore potential strategies for delaying immunosenescence to alleviate these age-related changes.